Common side effects include nausea, vomiting, and diarrhea during the first 24 weeks, typically resolved by week 68
By combining these mechanisms, researchers can evaluate how coordinated receptor signaling influences metabolic function compared with single- or dual-receptor agonists [4]
What isnt talked about as much, however, is that our bodies already produce GLP-1 on their own
Visit OMA's Advocacy webpage for more information on how to get involved and advocate for obesity medicine
Bristol-Myers Squibb and Company AdvaCare Pharma ANI Pharmaceuticals, Inc
However, it should be noted that GLP-1RAs can enhance sympathetic activity, potentially increasing heart rate and blood pressure, despite their cardioprotective properties [66]